Grant: Banting Postdoctoral Fellowship Program
McGill University
$140,000.00
The circadian clock and Alzheimer's disease pathology
EF 2020-21
Résumé
Alzheimer's disease (AD) is the most common dementia, in which afflicted patients progressively lose their cognitive and functional abilities, starting with memory. AD is incurable and a colossal burden to patients and caregivers' lives, and to society overall, with billions spent annually in Canada. Although we know that AD is caused by the accumulation of specific proteins in the brain (amyloid-beta and phosphorylated tau), we still do not completely understand how these accumulate and progress. Studying the circadian clock is a promising research avenue to better understand how AD develops: The circadian clock is composed of neuronal networks, genes and proteins in all cells of the body, which together regulates physiological functions (sleep-wake cycle, energy expenditure, inflammation) in phase with the 24 h light-dark cycle. Preliminary findings show that AD patients have disturbed circadian function, and that changes to the circadian clock may be associated with higher AD risk. Therefore, because the circadian clock regulates so many physiological functions, understanding the role of the circadian clock in the occurrence of AD might prove to be a key therapeutic target to prevent or even slow down the disease. In this project, we will use four different cohorts to investigate AD at all stages (healthy, people at risk, AD patients) to establish a causal model between the circadian clock (genes, proteins levels in brain tissue, circadian sleep markers) and AD (genes, AD diagnosis, cognition, amyloid and tau pathology, inflammation). Understanding the role of the circadian clock in the development of AD is imperative since circadian dysfunctions are treatable. Findings from this project will further our understanding of how people develop AD, and has the potential to result in possible circadian therapeutic strategies to prevent or delay AD, which remains a main cause of death and suffering in the elderly of Canada.
Programme
Banting Postdoctoral Fellowship Program
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
436296
Name
Baril Andrée-Ann
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
The circadian clock and Alzheimer's disease pathology
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Aging; Alzheimer'S Disease; Biomarkers; Circadian Clock; Circadian Rhythms; Cognition; Dementia; Genetics; Proteomics; Sleep Disturbances
Abstract
Alzheimer's disease (AD) is the most common dementia, in which afflicted patients progressively lose their cognitive and functional abilities, starting with memory. AD is incurable and a colossal burden to patients and caregivers' lives, and to society overall, with billions spent annually in Canada. Although we know that AD is caused by the accumulation of specific proteins in the brain (amyloid-beta and phosphorylated tau), we still do not completely understand how these accumulate and progress. Studying the circadian clock is a promising research avenue to better understand how AD develops: The circadian clock is composed of neuronal networks, genes and proteins in all cells of the body, which together regulates physiological functions (sleep-wake cycle, energy expenditure, inflammation) in phase with the 24 h light-dark cycle. Preliminary findings show that AD patients have disturbed circadian function, and that changes to the circadian clock may be associated with higher AD risk. Therefore, because the circadian clock regulates so many physiological functions, understanding the role of the circadian clock in the occurrence of AD might prove to be a key therapeutic target to prevent or even slow down the disease. In this project, we will use four different cohorts to investigate AD at all stages (healthy, people at risk, AD patients) to establish a causal model between the circadian clock (genes, proteins levels in brain tissue, circadian sleep markers) and AD (genes, AD diagnosis, cognition, amyloid and tau pathology, inflammation). Understanding the role of the circadian clock in the development of AD is imperative since circadian dysfunctions are treatable. Findings from this project will further our understanding of how people develop AD, and has the potential to result in possible circadian therapeutic strategies to prevent or delay AD, which remains a main cause of death and suffering in the elderly of Canada.
Competitiondate
202010
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Baril, Andrée-Ann
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~